Population and variability

1.
Chloe Hanson, Timothy Derebenskiy, Ana Rodriguez Vega, et al. Cell villages and Dirichlet modeling map human cell fitness genetics. The American Journal of Human Genetics. 2026. doi:10.1016/j.ajhg.2026.07.005
View Full Reference
1.
Jesse Weidema, Hanna Lammertse, Martine de Vries, Christine Mummery, Megan Munsie, Nienke de Graeff. Diversity-in-a-dish: A practical framework for hiPSC model development. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.102858
View Full Reference
1.
Felicity T. Enders, Philip M. Alberti, Elizabeth H. Golembiewski, et al. Measure Racism, Not Just Race: Recommendations for Scientific Practice. American Journal of Public Health. 2026;116(3):300-303. doi:10.2105/AJPH.2025.308393
View Full Reference
1.
Kian Hong Kock, Le Min Tan, Kyung Yeon Han, et al. Asian diversity in human immune cells. Cell. 2025;188(8):2288-2306.e24. doi:10.1016/j.cell.2025.02.017
View Full Reference
1.
Melpomeni Platani, Hao Jiang, Lindsay Davidson, et al. Screening for variable drug responses using human iPSC cohorts. PloS One. 2025;20(5):e0323953. doi:10.1371/journal.pone.0323953
View Full Reference
1.
Li Pang, Chengzhong Cai, Praful Aggarwal, et al. Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs-a proof-of-concept study with doxorubicin. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2024;200(1):79-94. doi:10.1093/toxsci/kfae041
View Full Reference
1.
Suel-Kee Kim, Seungmae Seo, Genevieve Stein-O’Brien, et al. Individual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells. Stem Cell Reports. 2024;19(9):1336-1350. doi:10.1016/j.stemcr.2024.07.004
View Full Reference
1.
Noelia Antón-Bolaños, Irene Faravelli, Tyler Faits, et al. Brain Chimeroids reveal individual susceptibility to neurotoxic triggers. Nature. 2024;631(8019):142-149. doi:10.1038/s41586-024-07578-8
View Full Reference
1.
Julia Y. Co, Jessica A. Klein, Serah Kang, Kimberly A. Homan. Toward Inclusivity in Preclinical Drug Development: A Proposition to Start with Intestinal Organoids. Advanced Biology. 2023;7(12):2200333. doi:10.1002/adbi.202200333
View Full Reference
1.
Alexandra R. Harris, Gatikrushna Panigrahi, Huaitian Liu, et al. Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor Ancestry. Cancer Research Communications. 2023;3(10):2014-2029. doi:10.1158/2767-9764.CRC-23-0236
View Full Reference